Senolytics target Alzheimer’s-linked brain enzymes without harming healthy ones: Using brain tissue samples from Alzheimer’s patients, scientists discovered that dasatinib and nintedanib, both senolytics, blocked enzymes associated with amyloid-beta plaques but did not affect normal brain enzymes.

1. Homepage
2. Science
3. Senolytics target Alzheimer’s-linked brain enzymes without harming healthy ones: Using brain tissue samples from Alzheimer’s patients, scientists discovered that dasatinib and nintedanib, both senolytics, blocked enzymes associated with amyloid-beta plaques but did not affect normal brain enzymes.